{
    "2021-03-25": [
        [
            {
                "time": "",
                "original_text": "医药行业发展迅猛，这些药企被看好",
                "features": {
                    "keywords": [
                        "医药行业",
                        "发展迅猛",
                        "药企",
                        "看好"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "阿斯利康新冠疫苗风波又起拿下中国代理权的康泰生物还好吗？",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "风波",
                        "康泰生物",
                        "代理权"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "新冠疫苗出现瑕疵，港澳叫停接种！“千亿医药股”市值大跳水！",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "瑕疵",
                        "港澳",
                        "叫停接种",
                        "市值跳水"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "现场直击丨医药数字化发展到了哪一步？",
                "features": {
                    "keywords": [
                        "医药",
                        "数字化",
                        "发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "阿斯利康新冠疫苗最新数据遭质疑，复星医药回应港澳暂停接种mRNA新冠疫苗",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "数据质疑",
                        "复星医药",
                        "港澳",
                        "暂停接种",
                        "mRNA"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "高度负责！复星医药新冠疫苗因少量瓶盖问题暂停在中国港澳注射大陆地区处在II期临床阶段",
                "features": {
                    "keywords": [
                        "复星医药",
                        "新冠疫苗",
                        "瓶盖问题",
                        "暂停注射",
                        "港澳",
                        "大陆",
                        "II期临床"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "每日财经观察：欧亚大动脉被“切断”！最新情况来了",
                "features": {
                    "keywords": [
                        "欧亚大动脉",
                        "切断",
                        "最新情况"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "全球经济"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}